Hosted on MSN

Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work

Valion Bio management framed Q1 2026 as the first period following its identity change to VBIO and emphasized federally funded progress for Entolimod under the FDA Animal Rule pathway, saying NIAID ...
Nasdaq

Gossamer Bio management to meet with Oppenhiemer

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Seeking Alpha

Bio-Rad Laboratories, Inc. (BIO) Management on Q2 2022 Results - Earnings Call Transcript

Good afternoon. Thank you for attending today's Bio-Rad Second Quarter 2022 Earnings Results Conference Call. My name is Hannah and I will be your moderator for today's call. All lines will be muted ...
Business Wire

Iveric Bio to Present at Upcoming Investor Conferences

PARSIPPANY, N.J.--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Iveric Bio management will participate in fireside chats at the following investor conferences in November: ...
Nature

Advanced predictive analytics for bio-waste management using YOLOv8-SPP to enhance waste prediction and sustainability in smart cities

The large volumes of bio-waste pose significant health and sanitation hazards. Effective bio-waste management involves value addition and conversion processes to enable the utilization of municipal ...